Cargando…
Genetic Control of Lithium Sensitivity and Regulation of Inositol Biosynthetic Genes
Lithium (Li(+)) is a common treatment for bipolar mood disorder, a major psychiatric illness with a lifetime prevalence of more than 1%. Risk of bipolar disorder is heavily influenced by genetic predisposition, but is a complex genetic trait and, to date, genetic studies have provided little insight...
Autores principales: | King, Jason, Keim, Melanie, Teo, Regina, Weening, Karin E., Kapur, Mridu, McQuillan, Karina, Ryves, Jonathan, Rogers, Ben, Dalton, Emma, Williams, Robin S. B., Harwood, Adrian J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887444/ https://www.ncbi.nlm.nih.gov/pubmed/20567601 http://dx.doi.org/10.1371/journal.pone.0011151 |
Ejemplares similares
-
Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity
por: Harwood, Adrian J
Publicado: (2011) -
Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases
por: Mukherjee, Sandip, et al.
Publicado: (2020) -
Glycogen Synthase Kinase-3 Is Required for Efficient Dictyostelium Chemotaxis
por: Teo, Regina, et al.
Publicado: (2010) -
Lithium induces autophagy by inhibiting inositol monophosphatase
por: Sarkar, Sovan, et al.
Publicado: (2005) -
The Inositol-3-Phosphate Synthase Biosynthetic Enzyme Has Distinct Catalytic and Metabolic Roles
por: Frej, Anna D., et al.
Publicado: (2016)